title: Effect of cognitive reserve markers on Alzheimer pathologic progression.
abstract: Education, occupation, premorbid intelligence, and brain size are surrogate markers for cognitive reserve. Whether these markers have biological influence on Alzheimer disease (AD) pathology is not known. We thus aimed to investigate the effect of cognitive reserve proxies on longitudinal change of AD biomarkers. A total of 819 participants with normal cognition, mild cognitive impairment, and mild AD were enrolled in the Alzheimer's Disease Neuroimaging Initiative and followed up with repeated measures of cerebrospinal fluid, positron emission tomography, and magnetic resonance imaging biomarkers. Generalized estimating equations were used to assess whether biomarker rates of change were modified by reserve proxies. Cerebrospinal fluid Aβ42 decline was slower in normal cognition participants with higher cognitive reserve indexed by education, occupation, and American National Adult Reading Test (ANART). The decline of [F] fluorodeoxyglucose positron emission tomography uptake was slower in AD participants with better performance on the ANART. Education, occupation, and ANART did not modify the rates of magnetic resonance imaging hippocampal atrophy in any group. These findings remained unchanged after accounting for APOE 4, longitudinal missing data, and baseline cognitive performance. Higher levels of reserve markers may slow the rate of amyloid deposition before cognitive impairment and preserve glucose metabolism at the dementia stage over the course of AD pathologic progression.
authors.affiliation: *Department of Neurology, Buddhist Tzu Chi General Hospital †College of Medicine, Tzu Chi University, Hualien, Taiwan ‡Division of Epidemiology, School of Public Health §Helen Wills Neuroscience Institute, University of California ∥Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA.
authors.forename: Raymond Y
authors.initials: RY
authors.lastname: Lo
authors.forename: William J
authors.initials: WJ
authors.lastname: Jagust
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000000981:diagnostic imaging / Q000473:pathology*; D015415:Biomarkers / Q000134:cerebrospinal fluid; D060825:Cognitive Dysfunction / Q000134:cerebrospinal fluid / Q000000981:diagnostic imaging / Q000473:pathology*; D058245:Cognitive Reserve / Q000502:physiology; D018450:Disease Progression; D005260:Female; D006624:Hippocampus / Q000000981:diagnostic imaging / Q000473:pathology*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods
chemical_list: D015415:Biomarkers
references.citation: JAMA. 1994 Apr 6;271(13):1004-10
references.pmid: 8139057
references.citation: Am J Epidemiol. 2004 Jan 15;159(2):175-83
references.pmid: 14718220
references.citation: Cell. 2005 Mar 11;120(5):701-13
references.pmid: 15766532
references.citation: Am J Ind Med. 2003 Feb;43(2):204-11
references.pmid: 12541276
references.citation: Ann Neurol. 1993 Mar;33(3):258-66
references.pmid: 8498809
references.citation: Neurosignals. 2008;16(1):19-23
references.pmid: 18097156
references.citation: Ann Neurol. 1988 Feb;23(2):138-44
references.pmid: 2897823
references.citation: Nat Neurosci. 2011 Jun;14(6):750-6
references.pmid: 21532579
references.citation: J Int Neuropsychol Soc. 2002 Mar;8(3):448-60
references.pmid: 11939702
references.citation: Hum Brain Mapp. 2011 Feb;32(2):282-9
references.pmid: 20336658
references.citation: Neurology. 2004 Apr 13;62(7):1184-6
references.pmid: 15079021
references.citation: Arch Neurol. 2011 Oct;68(10):1257-66
references.pmid: 21670386
references.citation: Arch Neurol. 1997 Nov;54(11):1399-405
references.pmid: 9362989
references.citation: Neurology. 2010 Jan 19;74(3):201-9
references.pmid: 20042704
references.citation: Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):205-12
references.pmid: 21946014
references.citation: Neurology. 1995 Jan;45(1):55-60
references.pmid: 7824135
references.citation: Biometrics. 1988 Dec;44(4):1049-60
references.pmid: 3233245
references.citation: J Neurosci. 2009 Feb 11;29(6):1860-73
references.pmid: 19211893
references.citation: J Magn Reson Imaging. 2008 Apr;27(4):685-91
references.pmid: 18302232
references.citation: J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):308-16
references.pmid: 16484637
references.citation: Neurology. 1997 Jul;49(1):30-7
references.pmid: 9222166
references.citation: Brain. 1999 Dec;122 ( Pt 12):2309-19
references.pmid: 10581224
references.citation: Epidemiology. 2010 Jul;21(4):467-74
references.pmid: 20220526
references.citation: Psychol Med. 1997 Nov;27(6):1337-44
references.pmid: 9403905
references.citation: Neurology. 2004 Oct 12;63(7):1198-202
references.pmid: 15477538
references.citation: Neurology. 1998 Jan;50(1):181-5
references.pmid: 9443477
references.citation: Lancet Neurol. 2010 Jan;9(1):119-28
references.pmid: 20083042
references.citation: J Public Health Med. 2000 Jun;22(2):182-90
references.pmid: 10912557
references.citation: Neurology. 2012 May 1;78(18):1376-82
references.pmid: 22491869
references.citation: Neurobiol Aging. 2011 Jul;32(7):1207-18
references.pmid: 19660834
references.citation: Neurology. 2002 Jul 23;59(2):272-4
references.pmid: 12136069
references.citation: Trends Cogn Sci. 2011 Nov;15(11):520-6
references.pmid: 21983147
references.citation: Neuron. 2005 Dec 22;48(6):913-22
references.pmid: 16364896
references.citation: Arch Neurol. 2012 May;69(5):623-29
references.pmid: 22271235